Page last updated: 2024-08-22

palladium and Adenocarcinoma

palladium has been researched along with Adenocarcinoma in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (3.85)	18.7374
1990's	8 (15.38)	18.2507
2000's	36 (69.23)	29.6817
2010's	6 (11.54)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Finger, PT; Nagendran, ST	1
Lin, L; Luo, H; Xu, Q; Zhang, B	1
Crook, J	1
Ko, EC; Stock, RG; Stone, NN	1
Brennan, JS; Christos, PJ; Goltser, Y; Nori, D; Parashar, B; Sabbas, AM; Shamis, M; Trichter, S; Wernicke, AG; Yan, W	1
Berkowitz, J; Blacksburg, SR; Stock, RG; Stone, NN	1
Boyd, JC; Chapman, TN; Makhlouf, AA; Theodorescu, D	1
Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE	1
Barker, J; Merrick, G; Wallner, K	1
Butler, W; Cavanagh, W; Ghaly, M; Merrick, G; Sutlief, S; True, L; Wallner, K	1
Beddar, S; Colussi, V; Dinchman, KH; Ellis, RJ; Fu, P; Kim, E; Kinsella, TJ; Resnick, M; Sodee, B; Spirnak, JP; Vertocnik, A; Young, B; Zhou, H	1
FERNANDEZ, C; FREDRICKSON, JM	1
Kollmeier, MA; Stock, RG; Stone, N	1
Lee, WR; Moughan, J; Owen, JB; Zelefsky, MJ	1
Chen, PY; Goldman, K; Grills, IS; Gustafson, GS; Hollander, M; Huang, R; Martinez, AA	1
Hoffelt, SC; Merrick, G; Wallner, K	1
Blute, ML; Frank, I	1
Broderick, GA; Buskirk, SJ; Igel, TC; Lisson, SW; Wehle, MJ; Young, PR	1
Colussi, V; Dinchman, KH; Ellis, RJ; Fu, P; Kim, E; Resnick, MI; Sodee, B; Spirnak, JP; Vertocnik, A; Young, B; Zhou, H	1
Fearn, P; Huang, D; Kattan, MW; Potters, L	1
Ellis, RJ; Kinsella, TJ; Kunos, CA; Resnick, MI	1
Adamovich, E; Butler, WM; Galbreath, RW; Merrick, GS; Wallner, KE	1
Bissonette, E; Miller, N; Smolkin, ME; Theodorescu, D	1
Bissonette, EA; Copp, H; Theodorescu, D	1
Carey, B; Swift, S	1
Dattoli, M; Fang, LC; Sorace, R; Taira, A; True, L; Wallner, K	1
Butler, W; Herstein, A; Merrick, G; Orio, P; Sutlief, S; Thornton, K; Wallner, K	1
Dibiase, SJ; Halabi, S; Hurwitz, MD; Keuttel, MR; McGinnis, LS; Ou, SS; Small, EJ	1
Balinska, M; Gerasimova, GK; Golenko, OD; Miasishcheva, NV	1
Cortes, E; Heffernan, M; Merimsky, O; Nori, D; Osian, AD; Turner, JW	1
DeWyngaert, JK; Lavagnini, P; Stock, RG; Stone, NN; Unger, PD	1
Davidian, M; Finger, PT; McCormick, SA; Walsh, JB	1
Hargis, R; Zachow, SE	1
Bice, WS; Kiefer, EJ; Prestidge, BR; Prete, JJ	1
Nori, D; Parikh, S	1
Behar, RJ; Cantor, A; Chovnick, SD; Huff, W; Otheguy, J; Perez, R; Sharkey, J; Solc, Z	1
Arger, P; Arjomandy, B; Broderick, GA; Epperson, RD; Kassaee, A; Malkowicz, SB; Whittington, R	1
Potters, L; Wang, XH; Yamada, Y	1
Behar, RJ; Cantor, A; Chovnick, SD; Donohue, M; Huff, W; Otheguy, J; Perez, R; Rabinowitz, R; Sharkey, J; Solc, Z; Steele, J; Webster, C	2
Dicker, AP; Leeper, DB; Lin, CC; Waterman, FM	1
Benson, ML; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, K	1
Calugaru, E; Cao, Y; Fearn, P; Potters, L; Torre, T; Wang, XH	1
Anscher, MS; Bowen, MG; Buckley, NJ; Chou, RH; Clough, RW; Das, SK; Dodge, RK; Ingram, SS; Joyner, RE; Kang, HL; Kang, SK; Kim, JH; Montana, GS; Sarmina, I; Steffey, BA; Whitehurst, AW; Zhou, SM	1
Smathers, S; Sprouse, J; True, L; Wallner, K	1
Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS	2
Antipas, V; Coles, IP; Dale, RG	1
Böhmer, D; Budach, V; Deger, S; Loening, SA; Roigas, J; Türk, I	1
Abel, LJ; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Stipetich, RL	1
Adamovich, E; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS	1
Anderson, RL; Butler, WM; Galbreath, RW; Kurko, BS; Lief, JH; Merrick, GS; Wallner, K	1

Reviews

3 review(s) available for palladium and Adenocarcinoma

Article	Year
The role of brachytherapy in the definitive management of prostate cancer. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2011, Volume: 15, Issue:3 Topics: Adenocarcinoma; Biopsy; Brachytherapy; Combined Modality Therapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Organs at Risk; Palladium; Patient Selection; Prostatic Neoplasms; Quality Assurance, Health Care; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Randomized Controlled Trials as Topic; Tomography, X-Ray Computed; Urination Disorders	2011
The current role of imaging for prostate brachytherapy. Cancer imaging : the official publication of the International Cancer Imaging Society, 2007, Feb-28, Volume: 7 Topics: Adenocarcinoma; Biomarkers, Tumor; Brachytherapy; Drug Implants; Fluoroscopy; Follow-Up Studies; Forecasting; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neoplasm Recurrence, Local; Organ Size; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Tumor Burden; Ultrasonography; Ultrasound, High-Intensity Focused, Transrectal; Urination Disorders	2007
Adenocarcinoma of the retinal pigment epithelium: a diagnostic and therapeutic challenge. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1996, Volume: 234 Suppl 1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Diagnosis, Differential; Eye Enucleation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmoscopy; Palladium; Pigment Epithelium of Eye; Radioisotopes; Retinal Diseases; Ultrasonography	1996

Trials

10 trial(s) available for palladium and Adenocarcinoma

Article	Year
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy. Urology, 2002, Volume: 60, Issue:4 Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Postoperative Complications; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders	2002
Gross hematuria after prostate brachytherapy. Urology, 2003, Volume: 61, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Follow-Up Studies; Hematuria; Humans; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome	2003
The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trials. International journal of radiation oncology, biology, physics, 2003, Apr-01, Volume: 55, Issue:5 Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Aged; Brachytherapy; Diarrhea; Dose Fractionation, Radiation; Follow-Up Studies; Hemorrhage; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy, High-Energy; Rectal Diseases; Urinary Incontinence; Urinary Retention	2003
Epididymitis after prostate brachytherapy. Urology, 2004, Volume: 63, Issue:2 Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Brachytherapy; Citrobacter freundii; Cohort Studies; Disease Susceptibility; Enterobacteriaceae Infections; Epididymitis; Escherichia coli Infections; Humans; Incidence; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Risk Factors; Surveys and Questionnaires; Time Factors	2004
There is a wide range of predictive dosimetric factors for I-125 and pd-103 prostate brachytherapy. American journal of clinical oncology, 2008, Volume: 31, Issue:1 Topics: Adenocarcinoma; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Risk Assessment; Survival Rate; Tomography, X-Ray Computed	2008
Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809. International journal of radiation oncology, biology, physics, 2008, Nov-01, Volume: 72, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgens; Biomarkers; Brachytherapy; Dose Fractionation, Radiation; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy, Conformal; Seminal Vesicles	2008
Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II study. Journal of surgical oncology, 1996, Volume: 61, Issue:4 Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Combined Modality Therapy; Feasibility Studies; Follow-Up Studies; Humans; Palladium; Palliative Care; Pancreatic Neoplasms; Prospective Studies; Radioisotopes; Survival Rate	1996
Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer, 1996, Jun-01, Volume: 77, Issue:11 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Biopsy; Brachytherapy; Combined Modality Therapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Life Tables; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Treatment Outcome; Ultrasonography; Urination Disorders	1996
A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. International journal of radiation oncology, biology, physics, 2001, Jul-01, Volume: 50, Issue:3 Topics: Adenocarcinoma; Brachytherapy; Cohort Studies; Disease-Free Survival; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Palladium; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Tomography, X-Ray Computed	2001
Interstitial hyperthermia using thermoseeds in combination with conformal radiotherapy for localized prostate cancer. Frontiers of radiation therapy and oncology, 2002, Volume: 36 Topics: Adenocarcinoma; Aged; Cobalt; Combined Modality Therapy; Drug Implants; Electromagnetic Phenomena; Follow-Up Studies; Hot Temperature; Humans; Hyperthermia, Induced; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Conformal; Treatment Outcome	2002

Other Studies

39 other study(ies) available for palladium and Adenocarcinoma

Article	Year
Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma. Ophthalmic surgery, lasers & imaging retina, 2015, Volume: 46, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brachytherapy; Eye Pain; Female; Glaucoma, Neovascular; Humans; Intraocular Pressure; Intravitreal Injections; Iodine Radioisotopes; Male; Melanoma; Middle Aged; Palladium; Radiation Injuries; Radioisotopes; Retrospective Studies; Uveal Neoplasms; Vascular Endothelial Growth Factor A; Visual Acuity	2015
Antitumor activity of a Trans-thiosemicarbazone schiff base palladium (II) complex on human gastric adenocarcinoma cells. Oncotarget, 2017, Feb-21, Volume: 8, Issue:8 Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Coordination Complexes; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Palladium; Schiff Bases; Stomach Neoplasms; Thiosemicarbazones; Xenograft Model Antitumor Assays	2017
PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure. International journal of radiation oncology, biology, physics, 2012, Jun-01, Volume: 83, Issue:2 Topics: Adenocarcinoma; Aged; Analysis of Variance; Brachytherapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Intensity-Modulated; Reference Values; Retrospective Studies; Risk	2012
Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapy. Urology, 2012, Volume: 79, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Disease-Free Survival; Hormones; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Palladium; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Intensity-Modulated; Risk Factors	2012
Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure. BJU international, 2012, Volume: 110, Issue:9 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Brachytherapy; Chemotherapy, Adjuvant; Follow-Up Studies; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Neoplasm Grading; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Treatment Failure	2012
Perioperative costs and charges of prostate brachytherapy and prostatectomy. Urology, 2002, Volume: 60, Issue:4 Topics: Adenocarcinoma; Brachytherapy; Fees and Charges; Fees, Medical; Health Care Costs; Hospital Charges; Hospital Costs; Humans; Male; Palladium; Prostatectomy; Prostatic Neoplasms; Radiation Oncology; Radioisotopes; Treatment Outcome	2002
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma. International journal of radiation oncology, biology, physics, 2003, Oct-01, Volume: 57, Issue:2 Topics: Adenocarcinoma; Aged; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunodetection; Radioisotopes; Radiotherapy Dosage; Time Factors	2003
VESTIBULAR DISORDERS IN FOURTH VENTRICLE LESIONS. EXPERIMENTAL STUDIES IN THE CAT. Archives of otolaryngology (Chicago, Ill. : 1960), 1964, Volume: 80 Topics: Adenocarcinoma; Cats; Cerebellum; Cerebral Ventricle Neoplasms; Cerebral Ventricles; Cold Temperature; Electrophysiology; Fourth Ventricle; Hot Temperature; Nystagmus, Pathologic; Palladium; Pathology; Radiation Effects; Radioisotopes; Research; Thyroid Neoplasms; Vestibular Diseases; Vestibule, Labyrinth	1964
Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality. International journal of radiation oncology, biology, physics, 2003, Nov-01, Volume: 57, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analysis of Variance; Androgen Antagonists; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Patient Selection; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Risk Assessment; Treatment Failure	2003
The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States. Cancer, 2003, Nov-01, Volume: 98, Issue:9 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal	2003
High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. The Journal of urology, 2004, Volume: 171, Issue:3 Topics: Adenocarcinoma; Aged; Brachytherapy; Follow-Up Studies; Humans; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiotherapy Dosage	2004
Defining the appropriate patient population for primary brachytherapy for localized prostate cancer: work in progress. Mayo Clinic proceedings, 2004, Volume: 79, Issue:3 Topics: Adenocarcinoma; Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Risk Factors	2004
Prediction of genitourinary tract morbidity after brachytherapy for prostate adenocarcinoma. Mayo Clinic proceedings, 2004, Volume: 79, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Brachytherapy; Dilatation; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Palladium; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Risk Factors; Transurethral Resection of Prostate; Urethral Stricture; Urinary Catheterization; Urinary Incontinence; Urodynamics	2004
Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinoma. Brachytherapy, 2003, Volume: 2, Issue:4 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Combined Modality Therapy; Humans; Indium Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioimmunodetection; Radioisotopes; Radiotherapy, Conformal; Risk Factors; Survival Analysis; Treatment Outcome	2003
The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy. Brachytherapy, 2003, Volume: 2, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; New York; Palladium; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Time Factors; Treatment Outcome	2003
Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator. Brachytherapy, 2004, Volume: 3, Issue:2 Topics: Adenocarcinoma; Brachytherapy; Foreign-Body Migration; Humans; Iodine Radioisotopes; Lung; Male; Palladium; Pelvis; Prostatic Neoplasms; Pulmonary Embolism; Radiography; Radioisotopes	2004
Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer. Urology, 2004, Volume: 64, Issue:4 Topics: Adenocarcinoma; Adult; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Life Tables; Male; Middle Aged; Neoplasm Invasiveness; Palladium; Proportional Hazards Models; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Radiotherapy, High-Energy; Risk; Treatment Outcome	2004
Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy. Cancer, 2005, Jun-15, Volume: 103, Issue:12 Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Enzyme Inhibitors; Finasteride; Humans; Leuprolide; Male; Neoadjuvant Therapy; Neoplasm Staging; Palladium; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Risk Factors; Survival Rate; Testosterone; Treatment Outcome; Ultrasonography, Interventional	2005
Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer. Urology, 2005, Volume: 65, Issue:6 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Brachytherapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Humans; Leuprolide; Male; Middle Aged; Neoadjuvant Therapy; Palladium; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes	2005
Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy. Urology, 2008, Volume: 71, Issue:1 Topics: Acid Phosphatase; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Humans; Male; Middle Aged; Multivariate Analysis; Palladium; Predictive Value of Tests; Proportional Hazards Models; Prostatic Neoplasms; Protein Tyrosine Phosphatases; Radioisotopes; Radiotherapy Dosage; Retrospective Studies	2008
[Methionine synthetase activity in tumor cells following administration of methylcobalamin and its analog]. Biulleten' eksperimental'noi biologii i meditsiny, 1981, Volume: 91, Issue:1 Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adenocarcinoma; Animals; Female; Mammary Neoplasms, Experimental; Methyltransferases; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Organometallic Compounds; Palladium; Vitamin B 12	1981
The use of transrectal ultrasound placement of radioactive seeds for the definitive treatment of prostate cancer. Journal of the Mississippi State Medical Association, 1996, Volume: 37, Issue:10 Topics: Adenocarcinoma; Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Ultrasonography	1996
Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy. International journal of radiation oncology, biology, physics, 1998, Mar-15, Volume: 40, Issue:5 Topics: Adenocarcinoma; Brachytherapy; Dose-Response Relationship, Radiation; Edema; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Ultrasonography	1998
Unresectable pancreatic adenocarcinoma treated with palladium-103 implant and chemoradiation. Journal of clinical gastroenterology, 1998, Volume: 26, Issue:2 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy, Needle; Brachytherapy; Deoxycytidine; Fatal Outcome; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Palladium; Pancreatic Neoplasms; Radioisotopes; Radiotherapy, Adjuvant; Tomography, X-Ray Computed	1998
Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients. Urology, 1998, Volume: 51, Issue:5 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Ambulatory Care; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brachytherapy; Chemotherapy, Adjuvant; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Ultrasonography, Interventional	1998
The effect of androgen deprivation on the early changes in prostate volume following transperineal ultrasound guided interstitial therapy for localized carcinoma of the prostate. International journal of radiation oncology, biology, physics, 1999, Jul-15, Volume: 44, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Dose-Response Relationship, Radiation; Goserelin; Humans; Iodine Radioisotopes; Leuprolide; Male; Palladium; Prostatic Neoplasms; Radiopharmaceuticals; Ultrasonography, Interventional	1999
A nomogram to compensate for intraoperative prostate edema during transperineal brachytherapy. Techniques in urology, 2000, Volume: 6, Issue:2 Topics: Adenocarcinoma; Aged; Algorithms; Brachytherapy; Edema; Endosonography; Humans; Intraoperative Complications; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Perineum; Prospective Studies; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Rectum; Tomography, X-Ray Computed	2000
Evolution of techniques for ultrasound-guided palladium 103 brachytherapy in 950 patients with prostate cancer. Techniques in urology, 2000, Volume: 6, Issue:2 Topics: Adenocarcinoma; Aged; Biopsy; Brachytherapy; Dose-Response Relationship, Radiation; Evaluation Studies as Topic; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Perineum; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Treatment Outcome; Ultrasonography	2000
Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry. Seminars in urologic oncology, 2000, Volume: 18, Issue:2 Topics: Adenocarcinoma; Algorithms; Brachytherapy; Cell Division; Cell Survival; Dose-Response Relationship, Radiation; Half-Life; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Therapeutic Equivalency; Time Factors	2000
Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy. Journal of endourology, 2000, Volume: 14, Issue:4 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Biopsy; Brachytherapy; Combined Modality Therapy; Flutamide; Humans; Leuprolide; Male; Middle Aged; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Ultrasonography	2000
A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction. International journal of radiation oncology, biology, physics, 2001, Jul-01, Volume: 50, Issue:3 Topics: Adenocarcinoma; Aged; Brachytherapy; Erectile Dysfunction; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Penis; Phosphodiesterase Inhibitors; Piperazines; Prostatic Neoplasms; Purines; Radiation Dosage; Radioisotopes; Retrospective Studies; Sildenafil Citrate; Sulfones	2001
Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method. International journal of radiation oncology, biology, physics, 2001, Jul-15, Volume: 50, Issue:4 Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Analysis of Variance; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Logistic Models; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Urination Disorders	2001
Temporary PSA rises and repeat prostate biopsies after brachytherapy. International journal of radiation oncology, biology, physics, 2001, Aug-01, Volume: 50, Issue:5 Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy; Brachytherapy; Diagnosis, Differential; False Positive Reactions; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Proteins; Neoplasm, Residual; Palladium; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radioisotopes; Salvage Therapy; Time Factors; Unnecessary Procedures	2001
Five-year biochemical outcome after prostate brachytherapy for hormone-naive men < or = 62 years of age. International journal of radiation oncology, biology, physics, 2001, Aug-01, Volume: 50, Issue:5 Topics: Adenocarcinoma; Adult; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Life Tables; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome	2001
Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer. International journal of radiation oncology, biology, physics, 2001, Sep-01, Volume: 51, Issue:1 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Brachytherapy; Disease-Free Survival; Gonadotropin-Releasing Hormone; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2001
A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd. Physics in medicine and biology, 2001, Volume: 46, Issue:10 Topics: Adenocarcinoma; Brachytherapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Neoplasms; Neoplasms, Squamous Cell; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy	2001
Erectile function after permanent prostate brachytherapy. International journal of radiation oncology, biology, physics, 2002, Mar-15, Volume: 52, Issue:4 Topics: Adenocarcinoma; Aged; Analysis of Variance; Brachytherapy; Coitus; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Penile Erection; Prostatic Neoplasms; Radioisotopes; Surveys and Questionnaires	2002
Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy. Urology, 2002, Volume: 60, Issue:1 Topics: Adenocarcinoma; Aged; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Treatment Outcome	2002
Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity. Urology, 2002, Volume: 60, Issue:1 Topics: Adenocarcinoma; Aged; Brachytherapy; Erectile Dysfunction; Health Status; Humans; Iodine Radioisotopes; Male; Middle Aged; Obesity; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiometry; Treatment Outcome; Urologic Diseases	2002